CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Pharmacy & Consumer Wellness Revenue by Source
Pharmacy & Consumer Wellness Revenue by Source — Products ($M)
Cvs Health Pharmacy & Consumer Wellness Revenue by Source: $33,152M in Q2 2026, up 0.6% from a year earlier.
Latest, Q2 2026
33,152
Period ended Jun 30, 2026
Change on a year earlier
+0.6%
32,942 in Q2 2025
History
32 quarters
Since Q3 2018
Sources
28
Documents cited below
Where the Q2 2026 figure comes from
“|| Products | $ | 33,152 | $ | 32,942 | $ | 64,491 | $ | 64,227 | $ | 210 | 0.6 | % | $ | 264 | 0.4 | %”
Source: CVS Health 10-Q (2026-08-05) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmacy & Consumer Wellness Revenue by Source — Products ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 33,152 | +0.6% | CVS Health 10-Q (2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 31,339 | +0.2% | CVS Health 10-Q (2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 36,845 | +12.2% | CVS Health 8-K (2026-02-10) ↗ |
| Q3 2025 | Sep 30, 2025 | 35,503 | +11.6% | CVS Health 10-Q (2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 32,942 | +12.6% | CVS Health 10-Q (2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 31,285 | +11.3% | CVS Health 10-Q (2026-05-06) ↗ |
| Q4 2024 | Dec 31, 2024 | 32,833 | +7.5% | CVS Health 8-K (2026-02-10) ↗ |
| Q3 2024 | Sep 30, 2024 | 31,823 | +13.5% | CVS Health 10-Q (2025-10-29) ↗ |
| Q2 2024 | Jun 30, 2024 | 29,252 | +3.9% | CVS Health 10-Q (2025-07-31) ↗ |
| Q1 2024 | Mar 31, 2024 | 28,120 | +3.2% | CVS Health 10-Q (2025-05-01) ↗ |
| Q4 2023 | Dec 31, 2023 | 30,534 | +10.1% | CVS Health 8-K (2025-02-12) ↗ |
| Q3 2023 | Sep 30, 2023 | 28,043 | +6.3% | CVS Health 10-Q (2024-11-06) ↗ |
| Q2 2023 | Jun 30, 2023 | 28,141 | +8.8% | CVS Health 10-Q (2024-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 27,258 | +9.5% | CVS Health 10-Q (2024-05-01) ↗ |
| Q4 2022 | Dec 31, 2022 | 27,726 | +8.0% | CVS Health 8-K (2024-02-07) ↗ |
| Q3 2022 | Sep 30, 2022 | 26,378 | +10.0% | CVS Health 10-Q (2023-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 25,870 | +9.6% | CVS Health 10-Q (2023-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 24,904 | +11.2% | CVS Health 10-Q (2023-05-03) ↗ |
| Q4 2021 | Dec 31, 2021 | 25,678 | +9.2% | CVS Health 8-K (2023-02-08) ↗ |
| Q3 2021 | Sep 30, 2021 | 23,971 | +6.9% | CVS Health 10-Q (2022-11-02) ↗ |
| Q2 2021 | Jun 30, 2021 | 23,609 | +9.9% | CVS Health 10-Q (2022-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 22,394 | -0.6% | CVS Health 10-Q (2022-05-04) ↗ |
| Q4 2020 | Dec 31, 2020 | 23,522 | +5.4% | CVS Health 8-K (2022-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 22,424 | +5.4% | CVS Health 10-Q (2021-11-03) ↗ |
| Q2 2020 | Jun 30, 2020 | 21,476 | +1.2% | CVS Health 10-Q (2021-08-04) ↗ |
| Q1 2020 | Mar 31, 2020 | 22,522 | +7.8% | CVS Health 10-Q (2021-05-04) ↗ |
| Q4 2019 | Dec 31, 2019 | 22,326 | +2.4% | CVS Health 8-K (2021-02-16) ↗ |
| Q3 2019 | Sep 30, 2019 | 21,273 | +2.9% | CVS Health 10-Q (2020-11-06) ↗ |
| Q2 2019 | Jun 30, 2019 | 21,230 | – | CVS Health 10-Q (2020-08-05) ↗ |
| Q1 2019 | Mar 31, 2019 | 20,900 | – | CVS Health 10-Q (2020-05-06) ↗ |
| Q4 2018 | Dec 31, 2018 | 21,793 | – | CVS Health 8-K (2020-02-12) ↗ |
| Q3 2018 | Sep 30, 2018 | 20,676 | – | CVS Health 8-K (2019-11-06) ↗ |
Cite this data
StockData. (2026). Cvs Health Pharmacy & Consumer Wellness Revenue by Source ($M), quarterly Q3 2018–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/pcw-rev-products
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.